JULIO
ARRIZABALAGA AGUIRREAZALDEGUI
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications en collaboration avec des chercheurs de Hospital Universitari de Bellvitge (12)
2017
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
2011
-
Restoration of T cell responses to Toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis
Clinical Infectious Diseases, Vol. 52, Núm. 5, pp. 662-670
2009
-
(Enfermedades Infecciosas y Microbiologia Clinica (2009) 27, 4, (222-235))
Enfermedades Infecciosas y Microbiologia Clinica
-
Delayed diagnosis of HIV infection in a multicenter cohort: Prevalence, risk factors, response to HAART and impact of mortality
Current HIV Research, Vol. 7, Núm. 2, pp. 224-230
-
The Spanish HIV BioBank: A model of cooperative HIV research
Retrovirology, Vol. 6
2000
-
Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish Earth-2 Study
Journal of Acquired Immune Deficiency Syndromes, Vol. 25, Núm. 1, pp. 26-35
-
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: The Scan Study
AIDS, Vol. 14, Núm. 16, pp. 2485-2494
-
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-Infected patients
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 19, Núm. 2, pp. 89-95
1999
1998
-
Recomendaciones sobre tratamiento antirretroviral
Medicina Clinica, Vol. 110, Núm. 3, pp. 109-116
-
Recomendaciones sobre tratamiento antirretroviral en 1998
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 16, Núm. 8, pp. 374-376